ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
19.11
-0.17 (-0.88%)
At close: Dec 29, 2025, 4:00 PM EST
19.00
-0.11 (-0.58%)
After-hours: Dec 29, 2025, 5:34 PM EST
ADMA Biologics Employees
ADMA Biologics had 685 employees as of December 31, 2024. The number of employees increased by 61 or 9.78% compared to the previous year.
Employees
685
Change (1Y)
61
Growth (1Y)
9.78%
Revenue / Employee
$713,225
Profits / Employee
$305,762
Market Cap
4.55B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 685 | 61 | 9.78% |
| Dec 31, 2023 | 624 | 7 | 1.13% |
| Dec 31, 2022 | 617 | 90 | 17.08% |
| Dec 31, 2021 | 527 | 120 | 29.48% |
| Dec 31, 2020 | 407 | 93 | 29.62% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ADMA News
- 5 weeks ago - ADMA Biologics: Why The Dip To $16 Resets The Buy Case - Seeking Alpha
- 7 weeks ago - ADMA Biologics, Inc. (ADMA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025 - GlobeNewsWire
- 2 months ago - 3 Biotech Stocks I Am Accumulating - Seeking Alpha
- 4 months ago - ADMA Biologics: Strong Product Mix, Growing Margins And Compelling Upside - Seeking Alpha
- 5 months ago - ADMA Biologics: Optionality With SG-001 And A Vertically Integrated IG Platform - Seeking Alpha
- 5 months ago - ADMA Biologics: A Better Quarter Than Headline Numbers - Seeking Alpha